Author,Title,Journal,ISSN,Publisher,Date,Volume,Number,Page,URL,URL(DOI)
Solange Peters and Rafal Dziadziuszko and Alessandro Morabito and Enriqueta Felip and Shirish M. Gadgeel and Parneet Cheema and Manuel Cobo and Zoran Andric and Carlos H. Barrios and Masafumi Yamaguchi and Eric Dansin and Pongwut Danchaivijitr and Melissa Johnson and Silvia Novello and Michael S. Mathisen and Sarah M. Shagan and Erica Schleifman and Jin Wang and Mark Yan and Simonetta Mocci and David Voong and David A. Fabrizio and David S. Shames and Todd Riehl and David R. Gandara and Tony Mok,Atezolizumab versus chemotherapy in advanced or metastatic NSCLC with high blood-based tumor mutational burden: primary analysis of BFAST cohort C randomized phase 3 trial,Nature Medicine,1078-8956,Springer Science and Business Media LLC,2022-08-22,28,,1831-1839,https://cir.nii.ac.jp/crid/1872272492359408512,https://doi.org/10.1038/s41591-022-01933-w